Difficulty: Medium
Average Score: 67%
Practice
A 70-year-old man admitted to the intensive care unit (ICU) for sepsis was recently given a diagnosis of syndrome of inappropriate antidiuresis. His serum sodium acutely fell from 130 mEq to 115 mEq/L during the past 3 days, and he recently seized secondarily to this problem. Which would be the most appropriate treatment option?
Correct answer
C
Rationale
The most appropriate treatment option for the 70-year-old man with syndrome of inappropriate antidiuresis (SIADH) and severe symptomatic hyponatremia is intravenous 3% sodium chloride (Option C). This hypertonic saline solution is the correct choice because it can rapidly increase the serum sodium levels, addressing the acute drop from 130 mEq to 115 mEq/L. The goal is to correct the hyponatremia quickly to prevent further neurological complications like seizures, as seen in this patient.
Intravenous 0.9% sodium chloride (Option A) is isotonic and will not provide the rapid correction needed in this critical situation. Intravenous DDAVP (desmopressin acetate) (Option B) is a medication used to treat conditions like diabetes insipidus by reducing urine production, which is not appropriate for treating hyponatremia. Intravenous conivaptan (Option D) is a vasopressin receptor antagonist used in euvolemic and hypervolemic hyponatremia cases but is not the first-line treatment for acute severe hyponatremia with neurological symptoms.
Educationally, understanding the importance of rapid correction of severe symptomatic hyponatremia due to SIADH with hypertonic saline is crucial for healthcare professionals managing such patients, especially in critical care settings like the ICU. Recognizing the appropriate treatment options based on the underlying pathophysiology and clinical presentation is essential for providing optimal patient care and preventing further complications.
Intravenous 0.9% sodium chloride (Option A) is isotonic and will not provide the rapid correction needed in this critical situation. Intravenous DDAVP (desmopressin acetate) (Option B) is a medication used to treat conditions like diabetes insipidus by reducing urine production, which is not appropriate for treating hyponatremia. Intravenous conivaptan (Option D) is a vasopressin receptor antagonist used in euvolemic and hypervolemic hyponatremia cases but is not the first-line treatment for acute severe hyponatremia with neurological symptoms.
Educationally, understanding the importance of rapid correction of severe symptomatic hyponatremia due to SIADH with hypertonic saline is crucial for healthcare professionals managing such patients, especially in critical care settings like the ICU. Recognizing the appropriate treatment options based on the underlying pathophysiology and clinical presentation is essential for providing optimal patient care and preventing further complications.